drugset / Trial / NCT04429139

Photodynamic Therapy With Visudyne for Human Retinoblastoma: A Preliminary Study

NCT04429139

Completed 8 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

To study the effectiveness and safety profiles of photodynamic therapy (PDT) for the treatment of human retinoblastoma.

Timeline

Start
2011-02-01
Primary completion
2018-05-30
Completion
2020-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Verteporfin Other / unclassified 6 mg/m2 Intravenous

Indications